Reduce PSA level to less than 4 in inclusion criteria: CDSCO Panel Tells Akum Drugs and Pharmaceuticals on FDC Dutasteride plus Silodosin Dr. Divya Colin18 April 2024 6:00 PM ISTNew Delhi: Reviewing the active post-marketing surveillance (PMS) protocol of fixed-dose combination (FDC) Dutasteride plus Silodosin presented by...
Sun Pharma gets CDSCO nod to manufacture, market FDC Silodosin JP plus Tadalafil Dr. Divya Colin7 Nov 2023 5:30 PM ISTNew Delhi: Based on the Phase III Clinical trial (CT) of the Fixed Dose Combination (FDC) Silodosin JP plus Tadalafil presented by the drug major Sun...
CDSCO Panel Rejects MSN Laboratories Proposal For Combikit of Silodosin Capsules plus Mirabegron Dr. Divya Colin15 Oct 2023 6:30 PM ISTNew Delhi: Highlighting that there is no unmet need for the proposed Combi kit of Silodosin Capsules 8mg/8mg plus Mirabegron extended released (ER)...
Silodosin effective medical expulsive therapy for patients with ureteral stones; study reveals Medha Baranwal31 Dec 2022 9:45 AM ISTIndonesia: A study investigating silodosin's efficacy as a medical expulsive therapy (MET) in patients with distal ureteral stones found that the...
Silodosin effective treatment option for refractory bladder pain syndrome among females Medha Baranwal18 Oct 2022 10:00 AM ISTPortugal: A study published in the Journal of Clinical Medicine found silodosin to be an effective and well-tolerated treatment for female refractory...
